Online inquiry

IVTScrip™ mRNA-Human ANKRD44, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A))   (CAT#: GTTS-WK17626MR)

This product GTTS-WK17626MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP. It ecodes the ANKRD44 protein. This product can be used in Lymphoid-primed multipotent progenitor cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP
5' Cap Cap 0
Species Human
RefSeq NM_001195144.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 91526
UniProt ID Q8N8A2
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ANKRD44, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) (GTTS-WK17626MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK25599MR IVTScrip™ mRNA-Human ARHGAP4, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ARHGAP4
GTTS-WK22038MR IVTScrip™ mRNA-Human ARL17A, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ARL17A
GTTS-WK25616MR IVTScrip™ mRNA-Human ARHGEF3, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ARHGEF3
GTTS-WK21157MR IVTScrip™ mRNA-Human AMOTL2, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA AMOTL2
GTTS-WK14536MR IVTScrip™ mRNA-Human alpha-Sarcoglycan, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA alpha-Sarcoglycan
GTTS-WK9798MR IVTScrip™ mRNA-Human ADAMTS1, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ADAMTS1
GTTS-WK13101MR IVTScrip™ mRNA-Human ADAMTS17, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ADAMTS17
GTTS-WK27963MR IVTScrip™ mRNA-Human ARF1, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) mRNA ARF1
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW